A population-based assessment of the familial component of acute kidney allograft rejection

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2575-2583

  Goldfarb Rumyantzev, Alexander S ^a,b   Shihab, Fuad ^c,d   Emerson, Lyska ^e   Mineau, Geraldine ^e,f   Schaefer, Carole ^f   Tang, Hongying ^a   Hunter, Cheri ^e   Naiman, Natalie ^b   Smith, Lonnie ^d   Kerber, Richard ^e,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Department of Biomedical Informatics ^*  (United States)

^c Division of Nephrology and Hypertension   (United States)

^d Solid Organ Transplant Program   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF UTAH   (United States)

Author keywords

Acute rejection; Familial; Genealogy; Kidney transplant; Outcome

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN; INTERLEUKIN 2 ANTIBODY; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENEALOGY; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PEDIGREE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 67651124891     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp086     Document Type: Article

References (31)

1. Ojo AO, Hanson JA, Wolfe RA et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307-313
2. Simmons RG, Abress L. Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis 1990; 15: 201-208
3. Eggers P. Comparison of treatment costs between dialysis and transplantation. Semin Nephrol 1992; 12: 284-289
4. Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol 2007; 67: 335-340
5. Salvadori M, Bertoni E, Rosati A et al. Post-transplant diabetes mellitus. J Nephrol 2003; 16: 626-634
6. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol 2005; 16: 1758-1774
7. Andres A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005; 56: 71-85
8. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005; 18: 643-650
9. Romagnoli J, Citterio F, Violi P et al. Post-transplant diabetes mellitus: a case-control analysis of the risk factors. Transpl Int 2005; 18: 309-312
10. Olyaei AJ, de Mattos AM, Bennett WM. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 2001; 7: 384-389
11. Matas AJ, Gillingham KJ, Payne WD et al. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857-859
12. Vadivel N, Tullius SG, Chandraker A. Chronic allograft nephropathy. Semin Nephrol 2007; 27: 414-429
13. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697-1701
14. Nickerson P, Jeffery J, Gough J et al. Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study. J Am Soc Nephrol 1999; 10: 1801-1805
15. Tinckam K, Rush D, Hutchinson I et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 2005; 79: 836-841
16. Skolnick M. The Utah genealogical data base: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M (eds). Banbury Report No 4: Cancer Incidence in Defined Populations. NewYork: Cold Spring Harbor Laboratory, 1980, 285-297
17. Cannon-Albright LA, Thomas A, Goldgar DE et al. Familiality of cancer in Utah. Cancer Res 1994; 54: 2378-2385
18. Wylie JE, Mineau GP. Biomedical databases: protecting privacy and promoting research. Trends Biotechnol 2003; 21: 113-116
19. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
20. Skolnick M, Bishop D, Carmelli D et al. A population-based assessment of familial cancer risk in Utah Mormon genealogies. In: Arrighi F, Rao P, Stubblefield E (eds). Genes, Chromosomes, and Neoplasia. New York: Raven Press, 1981, 477-500.
21. Gholami K, Thomas A. Alinear time algorithm for calculation ofmultiple pairwise kinship coefficients and the genetic index of familiality. Comput Biomed Res 1994; 27: 342-350
22. Malecot G. The Mathematics of Heredity. Paris: Masson, 1948
23. Kerber RA. Method for calculating risk associated with family history of a disease. Genet Epidemiol 1995; 12: 291-301
24. Goldfarb-Rumyantzev AS, Naiman N. Genetic prediction of renal transplant outcome. Curr Opin Nephrol Hypertens 2008; 17: 573-579
25. Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 674-677
26. Azarpira N, Aghdaie MH, Geramizadeh B et al. Cytokine gene polymorphisms in renal transplant recipients. Exp Clin Transplant 2006; 4: 528-531
27. Turner D, Grant SC, Yonan N et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64: 776-779
28. Sankaran D, Asderakis A, Ashraf S et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281-288
29. Johnson RW. Sirolimus (Rapamune) in renal transplantation. Curr Opin Nephrol Hypertens 2002; 11: 603-607
30. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004; 164: 1373-1388
31. Vincenti F, Mendez R, Curtis J et al. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. Transplantation 2005; 80: 910-916